Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence

INTRODUCTION: Dimethyl fumarate (DMF) has been recently approved as a disease-modifying therapy for the treatment of multiple sclerosis (MS). Post-marketing studies are important to confirm what was established in clinical trials. OBJECTIVE: To evaluate effectiveness and safety of DMF and to measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Alroughani, Raed, Ahmed, Samar Farouk, Behbehani, Raed, Al-Hashel, Jasem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700902/
https://www.ncbi.nlm.nih.gov/pubmed/28780745
http://dx.doi.org/10.1007/s40120-017-0080-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700902/
https://www.ncbi.nlm.nih.gov/pubmed/28780745
http://dx.doi.org/10.1007/s40120-017-0080-x

Ejemplares similares